EARNINGS PER SHARE. During the year ending December 31, 2013 earnings per share must increase at least $0.05 per share to attain the 20% assigned award. Cash Flow: 2012 cash flow from operations must be at least $21 million to trigger the award. To qualify for the full 20% award, cash flow must be $30 million or greater. Cash flow between $21 million and $30 million will be awarded in 2% increments up to the full 20% allocated award amount.
EARNINGS PER SHARE. In July 1997, the Financial Accounting Standards Board issued Statement No. 128, "Earnings Per Share." The Company has adopted the provisions of the new standard. In accordance with the statement, prior periods have not been restated as the effect of the change is not material. 49 ISIS PHARMACEUTICALS, INC. NOTES TO FINANCIAL STATEMENTS -- (CONTINUED) DECEMBER 31, 1998 The following table sets forth the computation of basic and diluted earnings per share: YEAR ENDED DECEMBER 31, 1998 1997 1996 Numerator: Numerator for basic net loss per share -- net loss.......................................... $(42,983) $(31,066) $(26,521) Numerator for diluted net loss per share -- net loss.......................................... $(42,983) $(31,066) $(26,521) Denominator: Denominator for basic net loss per share -- weighted average shares.............. 26,873 26,456 25,585 Denominator for diluted net loss per share -- weighted average shares.............. 26,873 26,456 25,585 Basic net loss per share........................... Diluted net loss per share......................... $ (1.60) ======== $ (1.60) ======== $ (1.17) ======== $ (1.17) ======== $ (1.04) ======== $ (1.04) ======== Options and warrants to purchase common stock were not included in the computation of diluted net loss per share because the effect would be antidilutive. For additional disclosures regarding outstanding stock options and warrants, see Note 4 -- Stockholders' equity. 1 EXHIBIT 10.23 CONFIDENTIAL TREATEMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 240.24b-2. * INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST THAT IS FILED SEPARATELY WITH THE COMMISSION. RESEARCH AND DEVELOPMENT AGREEMENT BETWEEN ISIS PHARMACEUTICALS, INC. AND ZENECA LIMITED
EARNINGS PER SHARE. For purposes of this Agreement, Earnings Per Share means net economic earnings per share as reported in the Company’s periodic reports filed with the Securities and Exchanges Commission reporting the results for quarterly and annual periods in the Performance Period. The number of shares of Common Stock used in calculating Earnings Per Share will be consistent with that number used to calculate the Company’s basic earnings per share in its periodic reports.
EARNINGS PER SHARE. Basic earnings (loss) per share is calculated by dividing profit (loss) for the period attributable to equity holders of the Company (excluding other comprehensive income) by the weighted average number of ordinary shares in issue during the period. The following table sets forth the computation of basic earnings (loss) per share: For the three-month periods ended March 31, Consolidated financial statements Separate financial statements 2020 2019 2020 2019 Profit (loss) for the period (Thousand Baht) 11,644 (47,816) (4,666) (66,477) Weighted average number of ordinary shares (Thousand shares) 9,587,147 6,163,166 9,587,147 6,163,166 Earnings per share (Baht per share) 0.0012 (0.0078) (0.0005) (0.0108)
EARNINGS PER SHARE. The calculation of the basic and diluted earnings per share attributable to the owners of the Company is based on the following data: Earnings for the year attributable to the owners of 2014 US$’000 2013US$’000 the Company 809 2,058 ’000 ’000 Weighted average number of ordinary shares for the purpose of basic earnings per share 921,498 920,985 Effect of dilutive potential ordinary shares in respect of share options 370 – Weighted average number of ordinary shares for the purpose of diluted earnings per share 921,868 920,985 During the year ended 30 June 2013, the calculation of diluted earnings per share did not assume the exercise of the Company’s outstanding share options as the exercise price of those share options was higher than the average market price for the year. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS Notes to the Consolidated Financial Statements For the year ended 30 June 2014 13. PROPERTY, PLANT AND EQUIPMENT Freehold land and building in the United States Leasehold improvements Plant and machinery Motor vehicles Furniture, fixtures and equipment Computer equipment Total US$’000 US$’000 US$’000 US$’000 US$’000 US$’000 US$’000 COSTAt 1 July 2012 3,416 5,314 14,886 343 905 3,305 28,169 Exchange adjustments – (30) 44 (5) – (53) (44) Additions – 20 287 90 21 24 442 Disposals/written off – (75) (23) (174) (7) (621) (900) At 30 June 2013 3,416 5,229 15,194 254 919 2,655 27,667 Exchange adjustments – (7) 3 (1) 1 (11) (15) Additions – 8 159 51 22 12 252 Disposals – (21) (420) – (23) (40) (504) At 30 June 2014 3,416 5,209 14,936 304 919 2,616 27,400 DEPRECIATIONAt 1 July 2012 79 4,177 12,489 311 726 2,592 20,374 Exchange adjustments – (19) (32) (2) – (44) (97) Provided for the year 60 137 1,334 22 49 251 1,853 Eliminated on disposals/written off – (46) (20) (174) (7) (352) (599) At 30 June 2013 139 4,249 13,771 157 768 2,447 21,531 Exchange adjustments – (5) (48) 1 (1) (9) (62) Provided for the year 60 83 906 34 50 75 1,208 Eliminated on disposals – (12) (404) – (19) (33) (468) At 30 June 2014 199 4,315 14,225 192 798 2,480 22,209 CARRYING VALUESAt 30 June 2014 3,217 894 711 112 121 136 5,191 At 30 June 2013 3,277 980 1,423 97 151 208 6,136 Included in freehold land and building is freehold land of US$1,064,000 (2013: US$1,064,000) which can be separated reliably. Notes to the Consolidated Financial Statements For the year ended 30 June 2014 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
EARNINGS PER SHARE. The Earnings Per Share of Common Stock shall mean the amount determined as follows:
EARNINGS PER SHARE. Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of shares outstanding during a period. Diluted earnings per share takes into consideration shares outstanding (computed under basic earnings per share) and potentially dilutive shares. The weighted average number of shares outstanding for the purposes of calculating basic earnings per share was 16,874,899 for the six months and three months ended June 30, 2002 and 2001, respectively. The weighted average number of shares outstanding for the purposes of calculating diluted earnings per share was 17,054,998 and 17,154,277 for the six months ended June 30, 2002 and 2001, respectively, and 17,093,390 and 17,089,806 for the three months ended June 30, 2002 and 2001, respectively.
EARNINGS PER SHARE. Basic earnings per share is calculated by dividing profit (loss) attributable to equity holders of the parent company for the period by weighted average number of ordinary shares that are issued and paid during the period. Consolidated Financial Statements Separate Financial Statements For the three-month periods For the three-month periods ended September 30, ended September 30, 2021 2020 2021 2020 Profit (loss) for the period (Thousand Baht) 39,225 (536) 43,284 1,071 Weighted average number of ordinary shares (Thousand Shares) 1,245,284 1,245,284 1,245,284 1,245,284 Basic earnings (loss) per share (Baht per share) 0.031 (0.0004) 0.035 0.0009 Consolidated Financial Statements Separate Financial Statements For the nine-month periods For the nine-month periods ended September 30, ended September 30, 2021 2020 2021 2020 Profit (loss) for the period (Thousand Baht) 171,613 67,923 187,897 71,933 Weighted average number of ordinary shares (Thousand Shares) 1,245,284 1,245,284 1,245,284 1,245,284 Basic earnings (loss) per share (Baht per share) 0.138 0.055 0.151 0.058 28. FAIR VALUE OF FINANCIAL INSTRUMENTS The Company uses the market approach to measure and disclosure their assets and liabilities that are required to be measured or disclosure at fair value by relevant financial reporting standards, except that the cost approach or income approach is used when there is no active market or when a quoted market price is not available. Fair value hierarchy Level 1 - Use of quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 - Use of inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (e.g. prices) or indirectly (e.g. derived from prices). Level 3 - Use of unobservable inputs such as estimates of future cash flows. As at September 30, 2021, the Company and its subsidiaries had the following assets and liabilities that were measured at fair value using different levels of inputs as follows :- In Thousand Baht Consolidated Financial Statements/ Separate Financial Statements Net book value Level 1 Level 2 Level 3 Total Assets measured at fair value Other current financial assets - Unit trust 498 - 585 - 585 Total 498 - 585 - 585 During the current period, there were no transfers within the fair value hierarchy. Valuation techniques and inputs to level 1 The fair value of investments in unit trusts that are not listed on the Stock Exchange of Thailand has been deter...
EARNINGS PER SHARE. Basic earnings per share is calculated by dividing the profit for the year by the weighted average number of ordinary shares which are issued and paid-up during the year. 2021 2020 Profit for the year (Baht) 258,437,436 72,198,250 Weighted average number of ordinary share (Shares) 149,909,264 149,909,264 Earnings per share (Baht per share) 1.72 0.48
EARNINGS PER SHARE. The Group presents earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the holding company by weighted average number of ordinary shares outstanding during the year.
